Registered Kenya · PPB

HIMANI FAST RELIEF HERBAL VAPOUR RUB

HINAMI

22332 CAMPHOR 9%, EUCALYPTUS OIL 6.7%, TURPENTINE OIL 5.5%, MENTHOL 3.5%, NUTMEG 0.55%, THYMOL 0.10%, HOLY BASIL 0.010%, CLOVE OIL 0.05% GENERIC/BIOSIMILARS

What it does

Hinami is a medication used to treat certain health conditions.

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
22332
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
HINAMI
Dosage form
CAMPHOR 9%, EUCALYPTUS OIL 6.7%, TURPENTINE OIL 5.5%, MENTHOL 3.5%, NUTMEG 0.55%, THYMOL 0.10%, HOLY BASIL 0.010%, CLOVE OIL 0.05%
Strength
-
Pack size
25ML
Therapeutic class
GENERIC/BIOSIMILARS
Manufacturer / MAH
Raa
Applicant / LTR
RAA LTD
Country of origin
FOREIGN
Manufacturer location
Inland Container Depot, ROAD, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 20:22:22 · updated 2026-07-26 09:21:40

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Hinami is a medication used to treat certain health conditions.

How it works

Hinami works by targeting specific processes in the body to help manage health issues.

Who it's for

Hinami is suitable for individuals with specific medical conditions as determined by a healthcare provider.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: hinami

Hinami is an emerging compound with potential therapeutic applications. Although specific details regarding its clinical use are limited, it is important to recognize that new pharmacological agents can offer innovative treatment options, particularly in specialized fields. The drug's development may be linked to various mechanisms impacting cellular processes, although detailed clinical guidelines and pharmacological data are still under investigation.

Dosage

Children: For paediatric dosing, consult the appropriate guidelines or pharmacological references, as specific data are not provided.

Adults: For dosing, refer to specific clinical guidelines or pharmacological references as established data are currently unavailable.

Mechanism of action

Hinami's precise mechanism of action is not fully elucidated, but it may interact with specific cellular pathways influencing metabolic processes or signaling cascades. It is essential to conduct further studies to clarify its pharmacological effects and target interactions.

Pharmacodynamics

The pharmacodynamics of Hinami are not well characterized in current literature. However, similar compounds often modulate receptor activity, enzyme inhibition, or other biochemical pathways that contribute to therapeutic effects. Understanding these dynamics is vital for predicting potential side effects and therapeutic windows.

Pharmacokinetics

The pharmacokinetics of Hinami, including absorption, distribution, metabolism, and excretion (ADME), have not been thoroughly established. Future studies will be crucial to determine its bioavailability, half-life, and clearance from the body, which will inform safe and effective dosing regimens.

PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.